Lexaria Bioscience Corp. Common Stock (LEXX)
Lexaria Bioscience Corp. (LEXX) is a technology company focused on developing and licensing proprietary drug delivery platforms that improve the bioavailability of orally consumed active compounds. Their innovations aim to enhance the absorption and effectiveness of pharmaceuticals and nutraceuticals, particularly in the sectors of cannabinoid and nicotine products. Founded with an emphasis on leveraging lipid-based technology, Lexaria aims to provide more efficient and safer delivery methods for various active ingredients.
Company News
Shares of Asana, Inc. (NYSE: ASAN) fell sharply during Tuesday’s session following soft FY25 revenue guidance. Asana reported quarterly losses of 4 cents per share which beat the analyst consensus estimate of losses of 10 cents by 60%. Quarterly sales came in at $171.1 million, beating the analyst consensus estimate of $167.676 million by 2.04%...
NEW YORK, Jan. 11, 2024 (GLOBE NEWSWIRE) -- NetworkNewsAudio – Lexaria Bioscience Corp. (NASDAQ: LEXX) announces the availability of a broadcast titled, “Exciting New Cures Possible from GLP-1 Diabetes, Weight-Loss Drugs.”